Mirataz for Cats - 20mg/g - 3g Tube
962673
Mirataz for Cats – Appetite Stimulant for Managing Weight Loss
Mirataz (mirtazapine transdermal ointment) is a prescription medication formulated to manage weight loss in cats suffering from various underlying health conditions. It is the first and only FDA-approved transdermal medication designed specifically for feline weight management. By stimulating appetite and increasing food intake, Mirataz helps cats regain and maintain their body weight without the need for oral administration.
Feline weight loss can be a symptom of serious medical conditions, including hyperthyroidism, chronic kidney disease, inflammatory bowel disease (IBD), neoplasia, pancreatitis, and liver failure. Cats experiencing these conditions often suffer from reduced appetite, which leads to malnutrition, muscle wasting, and further health complications. Mirataz provides an effective and well-tolerated solution for encouraging weight gain in affected cats.
How Mirataz Works
Mirataz contains the active ingredient mirtazapine, an antidepressant with appetite-stimulating properties. In cats, mirtazapine acts as a serotonin and histamine receptor antagonist, which helps to increase appetite, reduce nausea, and improve food consumption.
Unlike traditional oral medications, Mirataz is formulated as a transdermal ointment. It is applied directly to the inner pinna (ear flap) of the cat’s ear, allowing the medication to be absorbed through the skin. This method of administration eliminates the stress associated with giving pills or liquids, making it easier for both cats and their owners to manage treatment.
VETERINARY PRESCRIPTION REQUIRED
Product Features
- Pack Size: - 3g Tube
- Target Animal: - Cat (Feline)
- Related Condition: - Weight loss in Cats
- Pet Prescription Required?: - Yes
- Active Ingredient: - mirtazapine
- Product Name: - Mirataz for Cats - 5g Tube
More Information
Description
Mirataz for Cats - 20mg/g - 3g Tube
Benefits of Mirataz for Cats
Stimulates Appetite and Weight Gain
Mirataz is clinically proven to increase appetite and promote weight gain in cats experiencing unintentional weight loss. By encouraging food intake, it helps to stabilise body weight and prevent further decline in cats suffering from chronic illnesses.
Non-Oral Administration
Many cats are resistant to taking pills or liquid medications, making oral treatment challenging. Mirataz is applied as a transdermal ointment, reducing stress for both cats and owners. This method ensures proper dosing without the need for forceful administration.
Effective in Managing Weight Loss from Underlying Conditions
Feline weight loss is often linked to chronic illnesses. Mirataz is beneficial in managing weight loss caused by:
- Hyperthyroidism – Overactive thyroid glands increase metabolism, causing rapid weight loss despite normal or increased food intake. Mirataz encourages appetite and helps counteract weight loss.
- Chronic Kidney Disease (CKD) – Cats with CKD frequently experience reduced appetite due to nausea and metabolic imbalances. Mirataz helps improve appetite and food consumption.
- Inflammatory Bowel Disease (IBD) – Digestive tract inflammation leads to nutrient malabsorption and weight loss. Mirataz supports food intake, promoting better digestion and weight maintenance.
- Neoplasia (Cancer) – Cancer can suppress appetite, leading to significant weight loss and muscle wasting. Mirataz helps maintain weight by encouraging consistent food intake.
- Pancreatitis – Inflammation of the pancreas can cause nausea and decreased appetite. Mirataz works to counteract appetite suppression, improving overall nutrition.
- Liver Disease – Liver dysfunction affects metabolism and appetite regulation. Mirataz assists in increasing food consumption, helping to support liver function and prevent malnutrition.
How to Use Mirataz
Mirataz is applied once daily to the inner surface of the cat’s ear. The recommended dosage is a 1.5-inch strip of ointment (equivalent to 2 mg of mirtazapine), which should be spread evenly over the skin. Gloves should be worn during application to avoid accidental human absorption.
The ear should not be cleaned for at least six hours after application to ensure proper absorption. If contact with the medication occurs, the area should be washed thoroughly with soap and water. Treatment duration should be determined by a veterinarian, depending on the cat’s condition and response to the medication.
Safety and Precautions
Mirataz is generally well tolerated, but some cats may experience mild side effects. The most common adverse reactions include increased vocalisation, behavioural changes such as restlessness or hyperactivity, and occasional gastrointestinal disturbances. These effects are typically temporary and resolve with continued use.
Mirataz should not be used in cats with known hypersensitivity to mirtazapine or in those receiving serotonergic medications, as this may increase the risk of serotonin syndrome. It should be used with caution in cats with liver disease, as mirtazapine is metabolised by the liver.
Owners should monitor their cat’s appetite and weight gain throughout treatment and report any concerning changes to their veterinarian. If an overdose occurs, signs such as rapid heart rate, tremors, or agitation may develop, requiring immediate veterinary attention.
Storage and Handling
Mirataz should be stored at room temperature, away from moisture and direct sunlight. The tube should be tightly closed when not in use, and care should be taken to prevent accidental ingestion or skin exposure in humans.
You may also like
Cystaid Capsules for Cats - Pack of 30
Cystaid for Cats is a nutritional supplement designed to support and maintain a healthy bladder in felines. Cystaid is particularly beneficial for cats suffering from cystitis, a condition that causes inflammation of the bladder, often leading to discomfort and urinary problems.
Cystaid works by providing a source of glucosamine, a major component of the protective lining on the inside of the bladder. This lining, known as the glycosaminoglycan (GAG) layer, plays a crucial role in preventing harmful substances in urine from causing inflammation in the bladder wall. In cats with cystitis, this GAG layer can become compromised, leading to symptoms such as frequent urination, blood in the urine, and discomfort.
By supplementing with Cystaid for Cats, you're helping to stimulate the healthy production of glycosaminoglycans in the bladder, thereby relieving urinary and bladder discomfort. The capsules can be opened and mixed with food, or given whole, making administration simple and stress-free.
Pack of 30 Capsules
Defurr-UM Plus - Natural Cat Laxative - 70g Paste
Defurr-UM Paste aids in preventing the formation of hairballs in cats and kittens as well as helping in the removal of any which have already been formed
Droncit Spot-On for Cats 0.5ml - 4 tubes
Droncit Spot On is a popular treatment for tapeworm in cats. Droncit Spot On contains four tubes per box (4 month supply) and is suitable for use during pregnancy and lactation. The large tube size means one application will cover even large cats or kittens, and no messy tablets to give your pet.
Semintra Oral Solution for Cats - 30ml
Semintra for Cats is an oral medicine used in cats with chronic kidney disease (CKD) when there is excess protein in the urine (proteinuria). This 30ml bottle is a convenient option for smaller cats, for cats starting treatment, or where a smaller bottle suits your dispensing routine. Semintra is used under veterinary direction, because CKD care needs individual assessment and ongoing checks.
What is Semintra
Semintra contains telmisartan. Telmisartan belongs to a group of medicines called angiotensin II receptor blockers (ARBs). In cats with CKD, the kidney’s filtering units can become damaged and allow protein to leak into the urine. Semintra is used to reduce this protein loss.
Proteinuria matters because it is linked with faster progression of kidney damage in many cats. Reducing protein loss can therefore be an important treatment goal alongside diet and supportive care.
How Semintra works
Healthy kidneys filter waste into the urine while keeping most proteins in the bloodstream. In CKD, the tiny filters (glomeruli) and the surrounding tissue can be injured. This damage can increase pressure inside the filters and weaken the barrier that normally holds protein back.
Angiotensin II is a natural hormone that helps regulate blood pressure and fluid balance. In kidney disease, its effects can contribute to higher pressure within the glomeruli. Telmisartan blocks angiotensin II at specific receptors. This can lower pressure in the filters and reduce protein leakage into the urine. Your vet will usually monitor response with urine testing over time.
Telmisartan can also influence blood pressure. Cats with CKD can develop high blood pressure without obvious signs. Blood pressure monitoring is therefore common in CKD plans, even when Semintra is prescribed primarily for proteinuria.
30ml. VETERINARY PRESCRIPTION REQUIRED